AAAAAA

   
Results: 1-13 |
Results: 13

Authors: FUHRER D KUBISCH C SCHEIBLER U LAMESCH P KROHN K PASCHKE R
Citation: D. Fuhrer et al., THE EXTRACELLULAR THYROTROPIN RECEPTOR DOMAIN IS NOT A MAJOR CANDIDATE FOR MUTATIONS IN TOXIC THYROID-NODULES, Thyroid, 8(11), 1998, pp. 997-1001

Authors: KROHN K FUHRER D HOLZAPFEL HP PASCHKE R
Citation: K. Krohn et al., CLONAL ORIGIN OF TOXIC THYROID-NODULES WITH CONSTITUTIVELY ACTIVATINGTHYROTROPIN RECEPTOR MUTATIONS, The Journal of clinical endocrinology and metabolism, 83(1), 1998, pp. 130-134

Authors: FUHRER D ROTHE L COLLINOSDOBY P AVIOLI L OSDOBY P
Citation: D. Fuhrer et al., HUMAN OSTEOCLAST-LIKE CELL-DERIVED GRO-ALPHA INHIBITS OSTEOBLAST ALKALINE-PHOSPHATASE (AP) AND BONE SIALOPROTEIN EXPRESSION (BSP-1), Journal of bone and mineral research, 12, 1997, pp. 367-367

Authors: HOLZAPFEL HP FUHRER D WONEROW P WEINLAND G SCHERBAUM WA PASCHKE R
Citation: Hp. Holzapfel et al., IDENTIFICATION OF CONSTITUTIVELY ACTIVATING SOMATIC THYROTROPIN RECEPTOR MUTATIONS IN A SUBSET OF TOXIC MULTINODULAR GOITERS, The Journal of clinical endocrinology and metabolism, 82(12), 1997, pp. 4229-4233

Authors: FUHRER D WONEROW P WILLGERODT H PASCHKE R
Citation: D. Fuhrer et al., IDENTIFICATION OF A NEW THYROTROPIN RECEPTOR GERMLINE MUTATION (LEU(629)PHE) IN A FAMILY WITH NEONATAL ONSET OF AUTOSOMAL-DOMINANT NONAUTOIMMUNE HYPERTHYROIDISM, The Journal of clinical endocrinology and metabolism, 82(12), 1997, pp. 4234-4238

Authors: FUHRER D HOLZAPFEL HP WONEROW P SCHERBAUM WA PASCHKE R
Citation: D. Fuhrer et al., SOMATIC MUTATIONS IN THE THYROTROPIN RECEPTOR GENE AND NOT IN THE G(S)ALPHA PROTEIN GENE IN 31 TOXIC THYROID-NODULES, The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3885-3891

Authors: HAMMES HP WEISS A FUHRER D KRAMER HJ PAPAVASSILIS C GRIMMINGER F
Citation: Hp. Hammes et al., ACCELERATION OF EXPERIMENTAL DIABETIC-RETINOPATHY IN THE RAT BY OMEGA-3-FATTY-ACIDS, Diabetologia, 39(3), 1996, pp. 251-255

Authors: GRIMMINGER F GRIMM H FUHRER D PAPAVASSILIS C LINDEMANN G BLECHER C MAYER K TABESCH F KRAMER HJ STEVENS J SEEGER W
Citation: F. Grimminger et al., OMEGA-3 LIPID INFUSION IN A HEART ALLOTRANSPLANT MODEL - SHIFT IN FATTY-ACID AND LIPID MEDIATOR PROFILES AND PROLONGATION OF TRANSPLANT SURVIVAL, Circulation, 93(2), 1996, pp. 365-371

Authors: GRIMM H TIBELL A NORRLIND B SCHOTT J BOHLE RM PAPAVASSILIS C FUHRER D MAYER K GRIMMINGER F
Citation: H. Grimm et al., IMMUNOSUPPRESSIVITY OF PARENTERAL FAT EMU LSIONS UNDER DEFINED IMMUNOSTIMULATION, Infusionstherapie und Transfusionsmedizin, 22(2), 1995, pp. 110-116

Authors: MAYSER P FUHRER D SCHMIDT R GRUNDER K
Citation: P. Mayser et al., HYDROLYSIS OF FATTY-ACID ESTERS BY MALASSEZIA-FURFUR - DIFFERENT UTILIZATION DEPENDING ON ALCOHOL MOIETY, Acta dermato-venereologica, 75(2), 1995, pp. 105-109

Authors: GRIMMINGER F GRIMM H FUHRER D PAPAVASSILIS C MAYER K KISS I KRAMER HJ TEMMESFELD B SIBELIUS U SEEGER W
Citation: F. Grimminger et al., INTRAVENOUS N-3 LIPIDS - INFLUENCE ON MEDIATOR METABOLISM AND SURVIVAL OF HEART-TRANSPLANTS IN RATS, The FASEB journal, 8(5), 1994, pp. 10000646-10000646

Authors: GRIMMINGER F MAYSER P PAPAVASSILIS C THOMAS M SCHLOTZER E HEUER KU FUHRER D HINSCH KD WALMRATH D SCHILL WB SEEGER W
Citation: F. Grimminger et al., A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF N-3 FATTY-ACID BASED LIPID INFUSION IN ACUTE, EXTENDED GUTTATE PSORIASIS - RAPID IMPROVEMENT OF CLINICAL MANIFESTATIONS AND CHANGES IN NEUTROPHIL LEUKOTRIENE PROFILE, The Clinical investigator, 71(8), 1993, pp. 634-643

Authors: GRIMMINGER F FUHRER D PAPAVASSILIS C SCHLOTZER E MAYER K HEUER KU KISS L WALMRATH D PIBERHOFER S LUBBECKE F KRAMER HJ STEVENS J SCHUTTERLE G SEEGER W
Citation: F. Grimminger et al., INFLUENCE OF INTRAVENOUS N-3 LIPID SUPPLEMENTATION ON FATTY-ACID PROFILES AND LIPID MEDIATOR GENERATION IN A PATIENT WITH SEVERE ULCERATIVE-COLITIS, European journal of clinical investigation, 23(11), 1993, pp. 706-715
Risultati: 1-13 |